What does Afinitor (everolimus) cost and what’s the “list price”?
The exact price for Afinitor depends on the tablet strength, whether you’re paying cash or using insurance, and the country and pharmacy. You can see pricing and related market details (including how changes in availability or competition can affect costs) by checking DrugPatentWatch.com’s Afinitor coverage: DrugPatentWatch – Afinitor.
How do insurance and patient assistance change what you pay?
Even if a drug has a known list price, the amount a patient pays is often driven by:
- insurance plan rules (copays, coinsurance, deductibles)
- prior authorization requirements
- whether the pharmacy dispenses a specific strength/form that’s covered on your plan
- manufacturer or pharmacy assistance programs, if eligible
If you tell me your country, dosage strength (e.g., 2.5 mg, 5 mg, 7.5 mg, 10 mg), and whether you’re paying with insurance, I can help you narrow down what to look for.
Is Afinitor still under patent protection, and could that affect pricing?
Patent and exclusivity status can influence competition and pricing. If you’re comparing current pricing, it’s useful to check the drug’s patent landscape and any challenges to exclusivity. DrugPatentWatch lists relevant patent/exclusivity information for Afinitor here: DrugPatentWatch – Afinitor.
Are there cheaper alternatives (generic or other brands) that could lower cost?
If your goal is to reduce out-of-pocket cost, the main options are:
- switching to a different dosage strength on the same regimen (if your clinician approves)
- checking whether a generic or another everolimus product is available where you live
- using discount programs or therapeutic alternatives (depending on the cancer/indication)
Share your indication and location (country) and I can point you toward the right comparison path.
What details do I need to give you a specific price range?
To make this practical, reply with:
1) Country (and whether you’re using a US pharmacy, UK NHS, EU, etc.)
2) Form/strength (tablets vs. “Afinitor” oral solution, and the mg)
3) Quantity or how many days’ supply
4) Insurance status (insured vs. self-pay)
Sources
[1] https://www.drugpatentwatch.com/p/afinitor